#CTAD26: Biogen’s tau drug slows Alzheimer’s more after nearly two years
BOSTON — The benefits of Biogen's experimental Alzheimer's drug seem to get better with time. Over the summer, Biogen reported that the lowest dose of its gene-silencing therapy diranersen slowed the disease by ...
comments(0)
5-min edit window · permanent after that